Medical research

How to pick a winner in clinical drug trials

When a drug fails late on in clinical trials it's a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an 'adaptive' approach to clinical trials and a genetic ...

Medications

Amber warning for the UK's access to new medicines post Brexit

In an editorial to be published on Tuesday 27th June 2017 in the journal ecancermedicalscience, Anthony Hatswell of BresMed (an independent health economics consultancy) and University College London, explores the consequences ...

Health

Faster is better when it comes to sepsis care

Following the tragic and widely publicized death of Rory Staunton, 12, from undiagnosed sepsis in 2012, New York became the first state to require that hospitals follow a protocol to quickly identify and treat the condition.

Other

Brexit uncertainty hangs over EU medicines agency

Tasked with giving new medicines the go-ahead across the EU, the European Medicines Agency is likely to have to relocate from its London base after Brexit—a prospect that is worrying its chief Guido Rasi.

page 11 from 24